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Allele loss occurs frequently at hMLHI, but rarely at hAISH2, in sporadic
colorectal cancers with microsatellite instability
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Summary Mutations at the hMSH2 and hMLHI mismatch repair loci have been implicated in the
pathogenesis of colorectal cancer. Tumours with two allelic mutations at a mismatch repair locus develop
replication errors (RERs). In the hereditary non-polyposis colorectal cancer (HNPCC) syndrome, one mutation
is inherited and the other acquired somatically; in RER+ sporadic colorectal cancers, both mutations are
somatic. RER+ tumours tend to have a low frequency of allele loss, presumably because they acquire most
mutations through RERs. However, before a second mismatch repair mutation has occurred somatically, there
is no reason to suppose that allele loss occurs less frequently in tumours that are to become RER+. Indeed,
this second mutation might itself occur by allele loss. We have searched for allele loss at the hMSH2 and
hMLHI loci in RER+ and RER- sporadic colorectal cancers. Loss occurred at the hMLHl locus in 7/17
(41%) RER+ tumours, compared with 6/40 (15%) RER- cancers (X2=3.82, P-0.05). At hMSH2, 2/22
RER+ sporadic cancers (9%) had lost an allele, compared with 2/40 (5%) RER- cancers (X2=0.03, P>0.5).
Taken together with previous studies which focused on colorectal cancers from HNPCC families, the data
suggest that allele loss at hMLHI, but not at hMSH2, contributes to defective mismatch repair in inherited and
sporadic colorectal cancer.
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Germ-line mutations at the DNA mismatch repair loci
hMSH2, hMLHI, hPMSI and hPMS2 cause the hereditary
non-polyposis colorectal cancer (HNPCC) syndrome (Pelto-
maki, 1995). Patients develop carcinomas of the colon,
stomach, ovary, uterus and other specific sites (Jass et al.,
1994). The cancers of HNPCC patients show replication
errors (RERs), a manifestation of which is instability at
microsatellite loci (Fishel and Kolodner, 1995). Some
sporadic cases of colorectal cancer (CRC) also have
microsatellite instability, presumably because of somatically
acquired defects in mismatch repair (Aaltonen et al., 1993).
Mutations of mismatch repair genes have been found in
sporadic colorectal cancers (Liu et al., 1995).
It has been suggested that RERs comprise an alternative
to allele loss [loss of heterozygosity (LOH), allelic imbalance]
in the genetic pathways of colorectal tumorigenesis (Aaltonen
et al., 1993). Hence, whereas RER- tumours acquire many
mutations by LOH, RER+ tumours tend to acquire
mutations through errors of replication. This divergence
between genetic pathways can only occur, however, after the
cell becomes deficient in mismatch repair. If this deficiency is
recessive, as seems probable (Radman and Wagner, 1993),
two allelic mutations must first occur at the hMSH2,
hMLHI, hPMSI or hPMS2 loci (or some related locus). It
follows that in RER+ tumours, LOH may occur relatively
frequently at mismatch repair loci, thereby inactivating one
mismatch repair allele, in a way similar to allele loss at
tumour-suppressor loci.
This study determines whether or not allele loss at the
hMSH2 and hMLHI mismatch repair loci is important in the
pathogenesis of RER+ sporadic colorectal cancers. We have
characterised a set of sporadic colorectal cancers as RER+
and RER-. Allele loss at hMSH2 and hMLHI (the mismatch
repair loci most commonly involved in colorectal tumorigen-
esis) has been analysed in these cases. A set of colorectal
cancer cell lines has also been analysed with respect to RER
status and studied for LOH at hMSH2 and hMLHJ.
Materials and methods
Selection of sporadic CRC cases and CRC cell lines
Samples of sporadic CRC and matched normal tissue or
blood were obtained from the collection of St Mark's
Hospital, Harrow, UK. These cases were chosen at random
and were unselected with respect to family history. DNA was
extracted from tumours and normal tissue/blood using
standard methods. All visible normal tissue was removed
from tumours before extraction of DNA, but tumours were
not microdissected. A set of 24 sporadic CRCs was identified
as RER+, using the methods below, and 48 RER- CRCs
were chosen at random for comparison.
Thirty CRC cell lines were available from public sources,
from Imperial Cancer Research Fund sources or from
individual laboratories (Table I). The colorectal adenoma
cell line, PC/AA, was included in this group of samples.
DNA was extracted from these cell lines using standard
methods.
RER analysis in sporadic CRCs
Microsatellite instability was assessed at seven dinucleotide
repeat markers. PCR reactions were performed on each
tumour/normal pair using 50-250 ng DNA template in a
final volume of 50 Ml. The reaction mixture contained 1 x
standard PCR buffer (Promega), 1.5 mM Mg2", 0.5 mM
dNTPs, 0.4 mM of each specific oligonucleotide primer and
1 U Taq polymerase. The thermal cycling protocols were as
follows: for D6S434, Dl1S968, Dl1S901 and DIIS1313,
94°C (1 min)x 1, 94°C (1 min)/55°C (1 min)/72°C
(1 min) x 35, 72°C (5 min) x 1 (Gyapay et al., 1994); for
Dl1S29, 94°C (1 min) x 1, 94°C (1 min)/550C (1 min)/72°C
(1 min) x 30, 72°C (10 min) x 1 (Warnich et al., 1992); for
NCAM, 94°C (1 min) x 1, 94°C (1 min)/50°C (1 min)/72°C
(1 min) x 30, 72°C (5 min) x 1 (Telatar et al., 1994); and for
DRD2, 94°C (1 min) x 1, 94°C (30 s)/58°C (30 s)/74°C
(30 s) x 30, 74°C (5 min) x 1 (Hauge et al., 1991). After
heating to 90°C for 5 min the PCR products underwent
electrophoresis under denaturing conditions on a 6%
acrylamide sequencing gel (Sequagel) for 2-4 h. DNA was
blotted onto Hybond N+ membranes (Amersham, UK) and
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Table I Colorectal cancer cell lines studied, their RER status (from
this and previous studies), their mutations at hMSH2 and hMLHI
and the results of LOH analysis from this study
Name RER status Mutation 2p LOH? 3p LOH?
I HCT116 + MLH N N
2 COLO320DM - N N
3 SW620 - N N
4 SW480 - N N
5 SW837 - N N
6 SW1222 - N N
7 SW48 + MLH N N
8 T84 - N N
9 SW1417 N N
10 HT29 N N
11 WIDR N N
12 HCT15/DLDI + ? N N
13 COLO201 N N
14 COL0206 - N N
15 HCA46 N N
16 HCA7 + ? N N
17 JW N N
18 VACO5 + MLH N N
19 VACO4S - N N
20 CACO2 - N N
21 VACOlOMS - N N
22 SW948 - N N
23 LS174T + ? N N
24 LS411 + ? N N
25 LS1034 - N N
26 LIM1863 N N
27 SW403 - N N
28 LOVO + MSH N N
29 PC/AA N N
30 SKCO-1 N N
Blank entries, no mutation detected.;
PCR products were detected by the enhanced chemilumines-
cence technique (Amersham, UK), using a randomly
elongated oligonucleotide primer as a specific probe for
each locus. Membranes were exposed to Hyperfilm
(Amersham, UK) for up to 60 min to allow visualisation of
PCR products. Microsatellite instability was scored if extra
bands differing by 2 bp (one repeat unit) from the
constitutional DNA were present in the tumour DNA at
two or more of the microsatellite loci. If instability was
present at just one of the seven microsatellite loci, only cases
with more than one extra band were scored as RER+ (owing
to the possibility of false positives arising from random PCR
errors or from slippage of microsatellite repeat units
unrelated to mismatch repair defects).
Microsatellite instability and hMSH2/hMLH1 status of CRC
cell lines
Microsatellite instability is difficult to assess in the CRC cell
lines, because in nearly all cases, no constitutional DNA is
available for comparison with the tumour samples.
However, the fact that these tumour samples are not
contaminated by constitutional DNA (as may occur with
frozen tumour samples) means that such an assessment is
possible. The same loci and methods for determining
microsatellite instability were used for the cell lines as had
been used for the sporadic CRCs. In addition, published or
publicly-available information on the RER status and
mismatch repair genotypes of these cell lines was used
(Table I).
LOH at mismatch repair loci in sporadic CRCs
Allele loss was assessed at the D2S123 and D2S391
microsatellite loci (2pl5-pl6) in order to determine whether
or not LOH had occurred at hMSH2 (Figure 1). Allele loss at
hMLHI (Figure 1) was assessed using the D3S1611 and
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Figure 1 Genetic maps of the microsatellite markers used to
assess allele loss at hMSH2 (D2SJ23, D2S391, D2S288 and
D2S119) and at hMLHJ (D3S1611, D3S1612, D3S1277 and
D3S1561).
D3S1612 microsatellite loci (3p2l.3). PCR reactions were
performed as for locus D6S434 (see above and Gyapay et al.,
1994). PCR products were electrophoresed for 2-4 h on an
8% non-denaturing polyacrylamide gel and were detected by
silver-staining using standard methods. Allele loss was scored
by eye in informative (heterozygous) cases if the intensity of
one allelic band in the tumour DNA was diminished in
comparison with the other allele, allowing for the relative
intensity of the alleles in the constitutional DNA. If
microsatellite instability occurred at any locus, the results at
that locus were excluded from the LOH analysis and deemed
non-informative. In practice, no case showed instability at
both D2S123 and D2S391, or at both D3S1611 and
D3S1612.
LOH at mismatch repair loci in CRC cell lines
Owing to the absence of constitutional DNA in most
samples, allele loss could only be assessed indirectly in the
CRC cell lines using the following method. Given that about
20% of individuals are homozygous at any one of the
microsatellite markers used here, it is most unlikely (P=0.24
i.e. P-0.002) that an individual is homozygous in the germ
line at four of the markers. In fact, linkage disequilibrium
between closely linked markers and some degree of
consanguinity in marriages mean that the probability of
homozygosity is slightly greater than the value given.
Nevertheless, any tumour homozygous at four adjacent
markers has very probably lost an allele and is unlikely to
be a constitutional homozygote. Tumour cell lines lend
themselves well to this means of detecting LOH, because the
absence ofcontaminating normal DNA in the samples means
that tumour DNA can be analysed for homozygosity without
difficulty. One problem with the method is that very small
regions of LOH cannot be detected. For this reason,
microsatellite loci as close together as possible were chosen
from the Genethon map (Gyapay et al., 1994) to study LOH
at hMSH2 (D2S123, D2S391, D2S288 and D2SI19) and at
hMLHI (D3S1611, D3S1612, D3S1277 and D3S1561)
(Figure 1). PCR reactions were carried out as for D6S434
above and products were detected using the same method as
was used for study of LOH in the sporadic CRCs. As above,
any cases of microsatellite instability at the eight loci used to
assess LOH were excluded from the analysis and the tumour
deemed non-informative at that microsatellite locus.
Clinical data
From the sporadic cases, the following data were obtained:
patient age at presentation; Dukes' tumour stage; Jass
group; tumour grade (degree of differentiation); mucinous
differentiation; and tumour site in the colon(left- or right-
sided).
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Results
RER analysis
The set of 24 RER+ and 48 RER- sporadic CRC cases was
determined as described above. A negative association had
been found between the frequency of LOH and RER+
status in these tumours (Tomlinson and Bodmer, 1996). In
the CRG cell lines, microsatellite instability was confirmed in
those eight lines already reported as being RER+. All other
CRC lines were found to be RER- (Table I).
LOH at hMSH2 and hMLH1 in sporadic CRCs
In the sporadic CRCs, LOH occurred at the hMLHI locus
(Figure 2) in 7/17 (41%) RER+ tumours and in 6/40 (15%)
RER- CRCs (Table II). This difference is of borderline
significance at the 5% level (Table II). At hMSH2, a much
lower frequency of LOH was found (Figure 2). Of 22
informative RER+ tumours, two (9%) had lost an allele at
hMSH2; a similar frequency of allele loss (2 of 40 cases, 5%)
occurred at hMSH2 in the RER- CRCs (Table II).
None of the sporadic CRCs had lost an allele at one of the
two microsatellite loci used to study hMLHI, while retaining
alleles at the other locus. At hMSH2, however, one case had
lost an allele at D2S391, but not at D2S123; the significance
of this result is uncertain. Of the 51 sporadic CRCs, which
were informative at both hMSH2 and hMLHI, 15 (29%) lost
an allele at either hMSH2 or hMLHJ; eight of 17 (47%)
informative RER+ cancers lost an allele at either hMSH2 or
hMLHJ. No tumour had lost an allele at both hMSH2 and
hMLHI.
D3S1611 D3S1561
Case 58828
Case 175446
Case 693
Associations between clinical data and LOH in sporadic CRCs
There was no significant difference between the clinicopatho-
logical features of the RER+ and RER- tumours studied
here (details of statistical analyses not shown). There were
trends in the data towards the RER+ tumours having a
higher Dukes' stage and to being right-sided, in agreement
with other authors. By chance, however, there was a
predominance of left-sided colon cancers in our sample (63/
72, 87.5%) and this probably prevented a significant
association from being found between RER+ status and
right-sided tumours. We found no association between RER
status and patient age, the degree of tumour differentiation or
Jass score. Too few tumours showed mucinous differentiation
for a meaningful comparison to be made between the RER+
and RER- groups.
Further analysis showed no association between LOH at
hMLHI or hMSH2 and any of the clinical data (age, stage,
grade or site). This was true when all of the 72 sporadic
CRCs were included in the analysis, or when only the 24
RER+ CRCs were included.
LOH at hMSH2 and hMLHI in CRC cell lines
No cell line showed apparent homozygosity at all four
microsatellite loci analysed, whether close to hMSH2 or
hMLHJ. Indeed, every line was heterozygous at two or more
of the four microsatellite marker loci used to study hMSH2
or hMLHJ.
Discussion
We have detected a relatively high frequency of LOH (41%)
at hMLHI in sporadic RER+ colorectal cancers (that is,
tumours with microsatellite instability). This frequency may
slightly understate the true frequency of LOH, because
tumours were not microdissected from normal tissue. A
lower frequency of LOH (16%) occurred in RER- sporadic
CRCs. This frequency may reflect random events or truly
RER+ cancers in which microsatellite instability has not been
detected. At hMSH2, allele loss was uncommon in both
RER+ and RER- sporadic CRCs.
In 30 CRC cell lines studied, microsatellite instability was
confirmed in eight cases and not detected in the other 22
lines. We found no cell line that had lost an allele at hMLHI
or hMSH2 according to the criteria used in this study (see
above), although small regions of loss cannot be excluded at
hMSH2 in particular, because some of the markers used on
chromosome 2 were several cM apart (Figure 1). Some CRC
lines were apparently homozygous at the D2S391 and
D3S1611 loci, which are the closest markers known to
hMSH2 and hMLHI respectively, and it is possible that these
tumours had lost alleles. This fact, and the small number of
RER+ CRC cell lines identified, explain why the frequency of
LOH at hMLHI is apparently lower in the cell lines than in
the sporadic CRCs.
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Figure 2 Examples of allele loss at hMLHJ and hMSH2 in
sporadic colorectal cancers. Arrows denote 'lost' alleles. Case 226
is non-informative (constitutionally homozygous) at D2S391.
Table II Numbers of sporadic colorectal cancers subdivided
according to RER status and LOH at hMSH2 or hMLHI
hMLH1a hMLHIb
RERJ RER+ Total RER7 RER + Total
LOH 2 2 4 6 7 13
No LOH 38 20 58 34 10 44
40 22 62 40 17 57
aX2=0.03, P>0.5 (Yates' correction). bX2=3.82, P-0.05 (Yates'
correction). Informative cases only are shown (that is, cases that are
heterozygous at either of the two microsatellite loci used to study
hMSH2 and hMLHI). For both hMSH2 and hMLHI, LOH denotes
allele loss at either of the two microsatellite markers studied.
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The frequencies of LOH at hMSH2 and hMLHI reported
here are in agreement with the results of Hemminki et al.
(1994). This previous study found a frequency of allele loss of
56% at D3S1611 in a sample of nine informative cancers
from HNPCC patients and sporadic RER+ cancers.
Combined, the data suggest that, at hMLHI, mismatch
repair is dominant at the cellular level (that is, repair is
normal before a second 'hit' occurs). The frequency of allele
loss at hMLHI in the RER+ cancers (41%) is similar to that
found at many putative tumour-suppressor loci in CRCs
(Devilee et al., 1991).
Given the results at hMLHI and the apparently similar
effects of mutations at hMLHI and hMSH2, it is difficult to
explain the low frequency of allele loss at hMSH2 that was
found in this study and had also been found by Aaltonen et
al. (1993). One explanation is that LOH at hMSH2 and
hMLHI affects unusually small regions of the chromosome:
the markers used at hMLHJ lie within or close to the gene,
whereas the markers used for hMSH2 are up to 2cM away,
perhaps too far to detect some cases of LOH at hMSH2.
There are, however, other explanations for the difference
between allele loss at hMSH2 and hMLHI. The relative
frequencies of hMLHI and hMSH2 mutations in sporadic
CRCs are not fully known and it is possible that hMLHI
mutations are more common, the low frequency of LOH at
hMSH2 merely reflecting this fact (despite the finding that
germ-line hMSH2 mutations are actually more frequent than
hMLHI mutations in HNPCC). Alternatively, we can
speculate that LOH at hMSH2 is disadvantageous, pre-
sumably because of effects on the dosage of contiguous genes
with important cellular functions; the same reasoning may
not apply to hMLHJ. A further possibility is that hMSH2
mutations are at least partially dominant and that some
defect in mismatch repair in the 1.hMSH2/ +hMSH2 heterozygote
biases the second 'hit' towards mismatch repair mutations
away from LOH. Finally, we cannot discount the possibility
that LOH at hMLHI is not directly related to mismatch
repair, but primarily targets a nearby gene such as fl-catenin.
We conclude that allele loss at hMLHI probably
contributes to the RER+ status of a significant proportion
of sporadic colorectal cancers. Loss of heterozygosity at
hMSH2 appears to be rare. Allele loss at both these
mismatch repair loci occurs less frequently in RER- CRCs.
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